Navigation Links
Savient Announces Proposed Offering of $125 Million in Convertible Senior Notes
Date:1/31/2011

EAST BRUNSWICK, N.J., Jan. 31, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced its intention to offer, subject to market conditions and other factors, $125 million aggregate principal amount of Convertible Senior Notes due 2018 (the "Notes") pursuant to an automatically effective registration statement filed with the Securities and Exchange Commission today. Savient also intends to grant the underwriters an option to purchase up to an additional $18.75 million aggregate principal amount of Notes, solely to cover over-allotments. The interest rate, conversion price and other terms of the Notes will be determined by negotiations between Savient and the underwriters.

Savient expects to use the net proceeds of the offering to commercialize KRYSTEXXA™ in the United States, including completion of its ongoing efforts to recruit a sales force, expand its marketing organization and establish a commercial infrastructure, to fund clinical development activities directed to potential label expansion for KRYSTEXXA in the United States, to further develop and seek regulatory approval for KRYSTEXXA in jurisdictions outside the United States, particularly in the European Union, and for general corporate purposes, including working capital.

J. P. Morgan Securities LLC is acting as sole book-running manager of the offering. Lazard Capital Markets LLC is acting as a co-manager of the offering. A copy of the prospectus meeting the requirements of Section 10 of the Securities Act of 1933 may be obtained by contacting J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717; Telephone (631) 254-1735.

This press release is neither an offer to sell nor a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any jurisdiction in which
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... The Open Paradigm Project, in collaboration ... Psychiatry , and leading organizations in the movement ... media campaign showcasing video testimonials by individuals negatively ... on pathology and illness rather than wellness and ... Association,s (APA) rollout of its latest revision of ...
(Date:5/17/2013)... 2013 The power of plants to cure ... which mankind depends on the plant kingdom, is the ... Wild Medicine: Healing Plants Around the ... from May 18 through September 8, 2013. ... exhibition,s many attractions include a re-creation of the Western ...
(Date:5/17/2013)... , May 17, 2013  Lakeland Industries, Inc. (NASDAQ: ... protective clothing for industry, healthcare and to first responders ... its financial results for the fiscal 2013 fourth quarter ... 21, 2013 at stock market close and will conduct ... p.m. eastern. (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) ...
Breaking Medicine Technology:New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2
... TOWNSHIP, N.J., May 1, 2012  CentraState Medical Center ... from China on comprehensive imaging and interventional techniques ... is training with internationally distinguished interventional radiologist Ken ... CentraState and with Freehold Radiology Group. ...
... 1, 2012  Cohera Medical, Inc.®, a leading innovator and ... the treatment of the first patient in a prospective, ... Surgical Adhesive in the United States.  Initiation ... Company,s progression of the lead product toward commercialization in ...
Cached Medicine Technology:CentraState and Freehold Radiology Group train physicians from China 2CentraState and Freehold Radiology Group train physicians from China 3First Patient Treated in U.S. Clinical Study of Cohera Medical's TissuGlu® Surgical Adhesive 2First Patient Treated in U.S. Clinical Study of Cohera Medical's TissuGlu® Surgical Adhesive 3
(Date:5/19/2013)... FL (PRWEB) May 19, 2013 Exciting ... ®, who is reintroducing a great practice known through ... Brushing, also known as dry body brushing, has so ... Heshelow, founder of Sublime Beauty®. "We love that circulation ... of our largest organ, the skin, is supported through ...
(Date:5/19/2013)... Buenos Aires, Argentina: Yoga classes ( clases de ... Argentina by the Sivananda Yoga Vedanta Center. The ... (Barrio Norte). Classes are 90 minutes and are offered ... in a calm environment, allowing visitors to enjoy the ... food, among others. , The Yoga classes follow the ...
(Date:5/19/2013)... Minor fender benders and serious car accidents ... to the accident to respond appropriately to the situation. ... (CDC) data from 2010, accidents, including car accidents, are ... fact, in 2005, automobile accident-related deaths cost ... 2.3 million drivers and passengers receive treatment in an ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Cambridge House ... the St. Louis Metro East area, is hosting a Memorial ... Friday, May 24. , The community, which is located at ... of all incomes, including those on Medicaid, who need some ... delicious BBQ luncheon topped off by homemade ice cream for ...
(Date:5/18/2013)... 2013 The American Society for Gastrointestinal Endoscopy (ASGE) ... during the ninth annual ASGE Crystal Awards on Sunday, ... Foundation, this year,s event will begin at ... , Held in conjunction with Digestive Disease Week ... leadership, research and scientific pursuit. The event will recognize ...
Breaking Medicine News(10 mins):Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2Health News:Metro East Affordable Assisted Living Community to Host Memorial Day Weekend Barbecue 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 3Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 5Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 6Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 7
... Dr Foster website last week gives the public easy access to the ... ... November 28, 2008 -- Commerce Tuned have been working with Dr Foster ... website delivers the simplest access possible to the health information needed when ...
... some playthings unfit for kids, report claims , , FRIDAY, ... and plastic ponies containing the controversial compounds called phthalates. ... , Plastic pet animals that pose a choking hazard. ... aware that all these toys are in stores this ...
... Charities of,the New York Tri-State Area (RMHC-NYTSA) is awarding ... Students in the New,York, New Jersey and Connecticut (Fairfield ... or call 1-866-851-3994. The submission,deadline is February 16, ... RMHC U.S. Scholarship Program is part of our ongoing ...
... occurring proteins that contain selenium in human blood ... according to biochemists. , "We have found that ... negatively affects the replication of HIV," said K. ... and molecular toxicology. "Our results suggest a reduction ...
... JOHANNESBURG, South Africa, Nov. 27 20 top international,and ... annual African,Excellence Awards Banquet held tonight at the Michelangelo ... leading ideas and innovation,across a variety of sectors. , ... ) , ...
... 27 China West II today announced it has filed,an ... against,Genesis Pharmaceuticals (OTC Bulletin Board: GNPH), (Genesis) f/n/a Genesis,Technology Group, ... GEP,II,s failure to pay a $190,000 promissory note that became ... guarantee of 75% of the amount due under,the note. , ...
Cached Medicine News:Health News:Health Information at Your Fingertips with the Dr Foster Website Launch 2Health News:Beware of Toxic Toys This Holiday Season 2Health News:Beware of Toxic Toys This Holiday Season 3Health News:Ronald McDonald House Charities(R) of the New York Tri-State Area to Award Over $500,000 in Scholarships to Graduating High School Seniors 2Health News:Selenium may slow march of AIDS 2Health News:Frost & Sullivan Recognises Best-in-Class Innovators 2Health News:Frost & Sullivan Recognises Best-in-Class Innovators 3Health News:China West II Files Suit Against Genesis Pharmaceuticals and Capital Research Group Inc, Announces Conference Call Details 2
The Ultima 2000 SE is flexible in meeting the needs of both office and operating room use. It is the answer for the clinical practice with a wide range of ophthalmic demands looking for minimal risk ...
The VISULAS 532s combines ease of use, efficiency and safety to provide ophthalmologists with an overall system sharply focused on their requirements. ,The VISULAS 532s is a laser of many talent...
Two point fixation, tips separated by 13 mm. Each tip has 0.12 mm, 1 x 2 teeth. Flat serrated handle with polished finish. Without lock....
... for determining color vision abnormalities and testing ... be applied to many psychological and industrial ... four trays containing a total of 85 ... hue variation on one side and are ...
Medicine Products: